Skip to content
Company Analysis

Fresenius Medical Care AG FMS

A comprehensive view of key metrics, scores, and financial health for Fresenius Medical Care AG

Overview of Fresenius Medical Care AG

FMS NYQ
Healthcare Medical Care Facilities Large Cap
Fresenius Medical Care AG (FMS), is a Large Cap company, in the Medical Care Facilities industry, last closed at $22.62, about 209.4% undervalued vs fair value, -11.3% 1Y return, placing in the top 25% of its sector.
Metrics Rev Growth 1.5% ROE 6.8% Gross Margin 25.6% Div Yield 2.94%
$22.62
-0.49%
As of April 28, 2026
Previous close • Vol 90d: 30.0%
52-Week Range
Market Cap
$12.63B
Enterprise Value
$21.83B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Fair
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Fair
Completeness: 82%
Confidence: 90%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.freseniusmedicalca...
HQ Bad Homburg
Employees 109,698
Fiscal year Dec 31

Next Events

Earnings May 5

Fair Value Snapshot

Bear Base Bull
$62
$70
$79
Current: $22.62 +209% vs base

Engine Room Money Flow™

Large Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$19.6B
1.5%%
Gross Profit
$5.0B
5.7%%
Operating Income
$1.8B
24.5%%
Net Income
$978.0M
81.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio
172.5%
Excellent

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$2.9B
170.3% of FCF

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
2
Active Leaks
2/2
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Fresenius Medical Care AG's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
66
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Moderate
70
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing FMS's balance between Growth (20.0%), Profitability (43.8%), and Safety (36.1%). Growth 20% Safety 36% Profitability 44%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

28th percentile vs peers
29
Key Signals
EPS Growth YoY 7.8% 48p Rev Growth YoY 1.5% 25p TSR 8.3% 52p Revenue CAGR 3Y 0.4% 15p EPS CAGR 3Y -17.9% 16p
Strengths
  • Consistently strong margins across 6 metrics
Risks
  • Growth below peer median (percentile: 28)

Profitability

63th percentile vs peers
63
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

51th percentile vs peers
52
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Fresenius Medical Care AG.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$69.99
- - -
+209.4% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info